WEI Wei,QING Xiang-li,ZHANG Tao,et al.Thoughts and clinical experience of treating ulcerative colitis with traditional Chinese medicine[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(09):951-953.
WEI Wei,QING Xiang-li,ZHANG Tao,et al.Thoughts and clinical experience of treating ulcerative colitis with traditional Chinese medicine[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(09):951-953. DOI: 10.16025/j.1674-1307.2022.09.002.
Thoughts and clinical experience of treating ulcerative colitis with traditional Chinese medicine
YE L,CAO Q,CHENG J.Review of inflammatory bowel disease in China[J].Scientific World J,2013:296470.
QIU Y,REN W,LIU Y,et al.Disease burden of inflammatory bowel disease in China from 1990 to 2017:Findings from the global burden of diseases 2017[J].E Clin M,2020,27:100544.
BRUSCOLI S,FEBO M,RICCARDI C,et al.Glucocorticoid therapy in inflammatory bowel disease:mechanisms and clinical practice[J].Front Immunol,2021,12:691480.
DUBOIS-CAMACHO K,OTTUM PA,FRANCO-MUÑOZ D,et al.Glucocorticosteroid therapy in inflammatory bowel diseases:From clinical practice to molecular biology[J].World J Gastroenterol,2017,23(36):6628-6638.
BURR NE,GRACIE DJ,BLACK CJ,et al.Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis:systematic review and network meta-analysis[J].Gut,2021,doi:10.1136/gutjnl-2021-326390http://dx.doi.org/10.1136/gutjnl-2021-326390.
BARBERIO B,ZAMANI M,BLACK CJ,et al.Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease:a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol,2021,6(5):359-370.
FAIRBRASS KM,GRACIE DJ,FORD AC.Relative contribution of disease activity and psychological health to prognosis of inflammatory bowel disease during 6.5 years of longitudinal follow-up[J].Gastroenterology,2022,163(1):190-203.e5.